Absence of Survival Impact from Hepatitis During Immunotherapy in 193 Patients with Advanced Hepatocellular Carcinoma - An Observational Study from Taiwan.

MLA

Lin, Chi-Han, et al. “Absence of Survival Impact from Hepatitis During Immunotherapy in 193 Patients with Advanced Hepatocellular Carcinoma - An Observational Study from Taiwan.” Journal of Hepatocellular Carcinoma, vol. 11, Oct. 2024, pp. 1875–90. EBSCOhost, https://doi.org/10.2147/JHC.S464105.

APA

Lin, C.-H., Kuo, Y.-C., Kuo, H.-C., Wang, C.-T., Lin, S.-M., Lee, A. C.-W., Yu, M.-C., Lee, W.-C., Chen, C. C.-E., & Hsieh, J. C.-H. (2024). Absence of Survival Impact from Hepatitis During Immunotherapy in 193 Patients with Advanced Hepatocellular Carcinoma - An Observational Study from Taiwan. Journal of Hepatocellular Carcinoma, 11, 1875–1890. https://doi.org/10.2147/JHC.S464105

Chicago

Lin, Chi-Han, Yung-Chia Kuo, Hsuan-Chih Kuo, Ching-Ting Wang, Shi-Ming Lin, Alan Chao-Wei Lee, Ming-Chin Yu, Wei-Chen Lee, Cherry Chiao-Erh Chen, and Jason Chia-Hsun Hsieh. 2024. “Absence of Survival Impact from Hepatitis During Immunotherapy in 193 Patients with Advanced Hepatocellular Carcinoma - An Observational Study from Taiwan.” Journal of Hepatocellular Carcinoma 11 (October): 1875–90. doi:10.2147/JHC.S464105.